- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05264233
The Acute Effects of Meals Rich in Saturated or Unsaturated Fatty Acids on Postprandial Lipaemia in Healthy Men (CocoHeart)
February 21, 2022 updated by: Julie Lovegrove, University of Reading
Current dietary recommendations suggest that lowering intake of saturated fats or replacing it with unsaturated fats will decrease the risk of developing cardiovascular disease.
Coconut oil has gained popularity in recent years but it contains 90% saturated fat, which has higher percentage of saturated fat than butter.
To date, only limited studies have determined the acute effects of meals containing coconut oil on blood lipids, but findings are inconsistent.
Therefore, further studies are needed to address this knowledge gap and compare the postprandial effects of test meals rich in coconut oil with other sources of saturated fatty acids such as butter and unsaturated fatty acids (vegetable oils).
A cross-over, double-blind, randomised acute postprandial study will be conducted in 15 healthy men.
Participants will be assigned to consume the test meals rich in saturated or unsaturated fatty acids in random order on 3 separate occasions, with 3-4 weeks between each study visit.
Participants will be provided with breakfast (toast with jam and milkshake, 50g fat) and lunch (toast with jam and milkshake, 30g fat).
The anthropometric, blood pressure, arterial stiffness, and breath samples will be taken for each study visit.
Blood samples will be collected for the measurement of fasting lipids, glucose, insulin, inflammatory markers, whole blood culture as well as blood clotting.
Breath samples are collected for the measurement of gastric emptying as well as assessment of satiety using questionnaires (100 mm visual analogue scale) completed throughout the day.
The findings from this study will contribute to the evidence base on how consuming meals rich in coconut oil influence the level of blood lipids as well as other biomarkers for cardiovascular disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 6AP
- Department of Food and Nutritional Sciences, University of Reading
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy men
- Aged between 30 to 70 years
- Serum triacylglycerol < 2.3 mmol/l
- Body mass index between 19-32 kg/m2
- Total cholesterol < 7.5 mmol/l
Exclusion Criteria:
- Females
- Smokers
- Medical history of myocardial infarction or stroke in the past 12 months
- Diabetes (defined as fasting glucose > 7.0 mmol/l) or other endocrine disorders
- Kidney, liver, pancreas or gastrointestinal disorder
- Hypertension (blood pressure > 140/90 mmHg), cancer, medication for hyperlipidaemia (e.g. statins), hypertension or, inflammation
- Anaemia (<130 g/L haemoglobin)
- Taking any dietary supplements known to influence lipids/gut microbiota (e.g. plant stanols, fish oil, phytochemicals, natural laxatives, probiotics and prebiotics)
- Drinking in excess of 14 units of alcohol per week
- Planning on a weight-reducing regime
- Parallel participation in another dietary intervention study
- Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention and metabolic study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Meal rich in coconut oil
Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in coconut oil
|
50 g of coconut oil will be added to the test meal for breakfast and 30 g of coconut oil will be added to the test meal for lunch
|
ACTIVE_COMPARATOR: Meal rich in butter
Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in butter
|
50 g of butter will be added to the test meal for breakfast and 30 g of butter will be added to the test meal for lunch
|
ACTIVE_COMPARATOR: Meal rich in vegetable oil
Participants will be asked to consume a breakfast (0 minute) and lunch (330 minute) rich in vegetable oil
|
50 g of vegetable oil will be added to the test meal for breakfast and 30 g of vegetable oil will be added to the test meal for lunch
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in postprandial triacylglycerol
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
|
Triacylglycerol
|
Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting blood lipids
Time Frame: Acute study: taken at 0 (baseline)
|
Total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol
|
Acute study: taken at 0 (baseline)
|
Change from baseline in postprandial non-esterified fatty acids
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
|
Non-esterified fatty acids
|
Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
|
Change from baseline in postprandial insulin
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
|
Insulin
|
Acute study: taken at 0 (baseline), 30, 60, 90, 120, 180, 240, 300, 330, 360, 390, 420, 480 minutes
|
Change from baseline in postprandial vascular stiffness
Time Frame: Acute study: taken at 0 (baseline), 150, 315, 465 minutes
|
Measured via pulse wave assessment using the Mobil-O-graph device
|
Acute study: taken at 0 (baseline), 150, 315, 465 minutes
|
Change from baseline in postprandial blood pressure
Time Frame: Acute study: taken at 0 (baseline), 180, 300, 480 minutes
|
Systolic and diastolic blood pressure
|
Acute study: taken at 0 (baseline), 180, 300, 480 minutes
|
Change from baseline in postprandial thrombin generation
Time Frame: Acute study: taken at 0 (baseline), 180, 330, 480 minutes
|
Thrombin generation
|
Acute study: taken at 0 (baseline), 180, 330, 480 minutes
|
Change from baseline in postprandial gastric emptying
Time Frame: Acute study: taken at 15 minutes intervals between 0 min (baseline) and 480 minutes
|
Assessed using gas chromatography-mass spectrometry
|
Acute study: taken at 15 minutes intervals between 0 min (baseline) and 480 minutes
|
Appetite rating
Time Frame: Acute study: taken at 30 minutes intervals after the test meals up to 8 hours
|
Assessed using 100 mm visual analogue questionnaire
|
Acute study: taken at 30 minutes intervals after the test meals up to 8 hours
|
Change from baseline in postprandial gut hormones
Time Frame: Acute study: taken at 0 (baseline), 30, 60, 120, 240, 330, 360, 390 & 480 minutes
|
Ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide-1
|
Acute study: taken at 0 (baseline), 30, 60, 120, 240, 330, 360, 390 & 480 minutes
|
Change from baseline in postprandial endothelial activation
Time Frame: Acute study: taken at 0 (baseline),180, 300 and 420 minutes
|
E-selectin, P-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule-1
|
Acute study: taken at 0 (baseline),180, 300 and 420 minutes
|
Change from baseline in postprandial cytokine
Time Frame: Acute study: taken at 0 (baseline),180, 300 and 420 minutes
|
Interleukin 6, interleukin 1 beta, interleukin 10, tumour necrosis factor alpha, C-C motif chemokine ligand 5, C-X-C motif chemokine ligand 5
|
Acute study: taken at 0 (baseline),180, 300 and 420 minutes
|
Weight
Time Frame: Acute study: taken at 0 (baseline)
|
Body mass index will be calculated (kg/ height in m^2)
|
Acute study: taken at 0 (baseline)
|
Body composition
Time Frame: Acute study: taken at 0 (baseline)
|
Fat mass, fat free mass, trunk fat, trunk fat mass, trunk fat free mass
|
Acute study: taken at 0 (baseline)
|
Habitual diet assessment
Time Frame: Prior to the start of the study
|
4-day food diary
|
Prior to the start of the study
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Genotyping for apolipoprotein E
Time Frame: Acute study: taken at 0 (baseline)
|
Single nucleotide polymorphisms related to the metabolism of dietary fats
|
Acute study: taken at 0 (baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 13, 2020
Primary Completion (ACTUAL)
June 30, 2021
Study Completion (ACTUAL)
September 30, 2021
Study Registration Dates
First Submitted
December 16, 2021
First Submitted That Met QC Criteria
February 21, 2022
First Posted (ACTUAL)
March 3, 2022
Study Record Updates
Last Update Posted (ACTUAL)
March 3, 2022
Last Update Submitted That Met QC Criteria
February 21, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19/30
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityNorthShore University HealthSystem; Case Western Reserve University; Shirley... and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Coconut oil
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustCompletedMetabolic Ketosis | Cognitive Impairments, MildUnited Kingdom
-
Université de SherbrookeCompleted
-
NYU Langone HealthCompletedPsoriasis | Psoriatic ArthritisUnited States
-
Gadjah Mada UniversityUnknownCoronavirus InfectionsIndonesia
-
Universidade Federal do Rio de JaneiroConselho Nacional de Desenvolvimento Científico e Tecnológico; Rio de Janeiro...Unknown
-
Rowan UniversitySuspendedMuscle Strength | Neuromuscular Function | Fat-free MasssUnited States
-
National University, SingaporeClinical Nutrition Research Centre, SingaporeCompletedCarotenoidsSingapore
-
Malaysia Palm Oil BoardInternational Medical University (IMU), Kuala Lumpur,MalaysiaCompleted
-
University of JordanCompleted
-
Unity Health TorontoUnknown